Table 2 Procedures, treatments and outcome.
| Men (%) (n = 34 020) | Women (%) (n = 19 761) | OR* before adjustment (95% CI) | OR* after age‐adjustment (95% CI) | OR* after multiple adjustment† (95% CI) | |
|---|---|---|---|---|---|
| Treatment | |||||
| Heparin/LMWH | 59 | 56 | 1.11 (1.07–1.15) | 1.02 (0.98–1.06) | 1.02 (0.98–1.07) |
| Nitroglycerin iv | 32 | 32 | 1.00 (0.96–1.03) | 0.99 (0.96–1.03) | 0.98 (0.94–1.03) |
| GPIIb/IIIa inhibitor | 6 | 4 | 1.43 (1.31–1.56) | 1.22 (1.11–1.34) | 1.18 (1.07–1.30) |
| Procedures‡ | |||||
| Stress test | 28 | 20 | 1.56 (1.50–1.63) | 1.31 (1.25–1.37) | 1.34 (1.27–1.40) |
| Echocardiography | 44 | 40 | 1.17 (1.13–1.21) | 1.10 (1.06–1.14) | 1.11 (1.06–1.15) |
| Coronary angiography | 37 | 29 | 1.44 (1.38–1.49) | 1.12 (1.07–1.16) | 1.10 (1.05–1.15) |
| PCI | 18 | 14 | 1.35 (1.28–1.42) | 1.07 (1.02–1.13) | 1.03 (0.97–1.09) |
| CABG | 7 | 5 | 1.55 (1.43–1.68) | 1.40 (1.29–1.52) | 1.43 (1.31–1.57) |
| PCI/CABG | 24 | 18 | 1.45 (1.38–1.51) | 1.17 (1.11–1.22) | 1.15 (1.09–1.21) |
| Medication at discharge | |||||
| ACE inhibitor | 37 | 36 | 1.04 (1.00–1.07) | 1.10 (1.06–1.14) | 1.13 (1.07–1.19) |
| Aspirin/other thrombocyte inhibitor | 88 | 85 | 1.22 (1.15–1.28) | 1.04 (0.98–1.09) | 1.02 (0.96–1.09) |
| β‐blocker | 82 | 78 | 1.23 (1.17–1.28) | 1.04 (1.00–1.09) | 1.06 (1.00–1.12) |
| Lipid‐lowering drugs | 51 | 45 | 1.30 (1.25–1.35) | 0.99 (0.95–1.03) | 0.98 (0.94–1.03) |
| Mortality (all‐cause) | |||||
| In‐hospital | 5 | 7 | 0.74 (0.69–0.80) | 1.03 (0.96–1.11) | 1.03 (0.94–1.13) |
| 30 days | 7 | 9 | 0.76 (0.71–0.81) | 1.05 (0.98–1.12) | 1.07 (0.99–1.15) |
| 1 year | 16 | 19 | 0.77 (0.74–0.81) | 1.11 (1.05–1.16) | 1.12 (1.06–1.19) |
Data are given as percentages unless otherwise indicated.
CABG, coronary artery bypass grafting; GPIIb/IIIa, glycoprotein IIb/IIIa; LMWH, low molecular weight heparin; PCI, percutaneous coronary intervention;
*Odds ratios were obtained by logistic regression analysis and presented as OR for men vs women.
†Multivariate logistic regression model with adjustment for age, gender, smoking status, previous myocardial infarction, PCI or CABG, history of hypertension, diabetes, congestive heart failure, renal failure, stroke, chronic obstructive pulmonary disease or malignant disease during last 3 years, information on medical treatment before admission (including ACE inhibitors, aspirin, oral anticoagulants, heparin, LMWH, β‐blockers, long‐acting nitroglycerine, lipid‐lowering drugs, digitalis and diuretics), ST‐segment depression on admission, cardiopulmonary resuscitation immediately before admission and elevation of biochemical markers (defined as CKMB⩾10 μg/l or TnT⩾0.1 μg/l).
‡Performed during hospital stay.